EF
VNDA icon

Empowered Funds’s Vanda Pharmaceuticals VNDA Stock Holding History

Empowered Funds’s Portfolio VNDA Stock Details VNDA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-228,287
Closed -$1.07M – 1732
2024
Q3 		$1.07M Buy
228,287
+11,524
+5% +$61.8K 0.02% 883
2024
Q2 		$1.22M Buy
216,763
+15,480
+8% +$80K 0.02% 791
2024
Q1 		$827K Buy
201,283
+15,215
+8% +$60.9K 0.01% 950
2023
Q4 		$785K Buy
186,068
+16,789
+10% +$67.7K 0.02% 862
2023
Q3 		$731K Buy
169,279
+13,904
+9% +$77.3K 0.02% 778
2023
Q2 		$1.02M Buy
+155,375
New +$996K 0.04% 603

Other funds holding VNDA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

Empowered Funds's VNDA Position: Q4 2024 in Review

Empowered Funds sold out of Vanda Pharmaceuticals (VNDA) in Q4 2024, closing a stake of 228,287 shares — an estimated $1.07M sold.

Empowered Funds first reported a position in VNDA in Q2 2023 and held it in 6 quarters. The position peaked at $1.22M in Q2 2024. 146 funds tracked by Wall St. Rank hold VNDA as of Q4 2024.

  • Empowered Funds reported no remaining Vanda Pharmaceuticals position as of Q4 2024 after selling out during the quarter.
  • Empowered Funds sold 228,287 Vanda Pharmaceuticals shares in Q4 2024, an estimated $1.07M.
  • Empowered Funds first reported a position in Vanda Pharmaceuticals in Q2 2023 and held it in 6 quarters.
  • Empowered Funds's Vanda Pharmaceuticals position peaked at $1.22M in Q2 2024.
  • 146 funds tracked by Wall St. Rank held Vanda Pharmaceuticals as of Q4 2024.

Based on Empowered Funds's 13F filing for Q4 2024, filed 28 Jan 2025.